| CAS ID: | 58001-44-8 |
| Molecular Formula: | C8H9NO5 |
| Molecular Weight: | 199.2 g/mol |
| Monoisotopic Mass: | 199.0481 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | BRL 14151 | Clavulanic Acid | Clavulanate | BRL 14151K | CLAVULANATE POTASSIUM |
| Analysis: | Drug repositioning mechanism analysis |
Reference Record 1
| PubMed ID | 22018680 | Target ID | |
| Uniprot ID | Name | ||
| Model | human | Fibrosis Disease | Cystic fibrosis |
| Process I | |||
| Process II | |||
| Process III | |||
| Mechanism | |||
Trial Record 1
| ClinicalTrial ID | NCT00153634 | Disease | Cystic fibrosis |
| Phase | Not Applicable | Status | Completed |
| First Received | September 12, 2005 | Last Verified | March 13, 2008 |
| Sponsor | Seattle Children's Hospital | ||